Prevention and Management of Recurrent C. difficile: Managed
Care Considerations for Improved Patient Outcomes
A continuing medical
education activity sponsored by NAMCP and AAMCN
Prevention and Management of Recurrent C. difficile: Managed Care
for Improved Patient Outcomes is a two-part webinar series focusing
on the latest
developments in the treatment and prevention of C. Difficile
These are archives of live webinars held between June 23 and July 1,
If you participated in any of the live webinars, you are not
eligible to claim credit from the archive of that webinar.
By clicking on each of the titles, you will be able to participate
in each part.
It is not required that you participate in each, or in order.
These activities are valid from August 1, 2020 to August 1, 2022
series is supported by an educational grant from Merck & Co.
This activity is intended for healthcare professionals practicing in managed
Instructions for CME/NCPD: Complete the pre-test,
listen to the audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name and email
address on the pre-test, evaluation and post-test. If you close your internet
browser without completing the post test, you will have ONE more opportunity to
complete. A score of 70% must be achieved on the post test to receive continuing
education credits. If you do not pass the post test after two attempts, you will
not be eligible to try again. Once you complete the evaluation form and score
70% or higher on your post test, you will automatically be given your
The epidemiology and incidence of hospital- and
community-acquired Clostridium difficile infection (CDI) has changed over the
past decade resulting in increased cases of initial and recurrent infection. Up
to 25% of patients with an initial episode of CDI experience disease recurrence.
Recurrent CDI is particularly challenging to manage.